Cellogen Therapeutics raises Rs 20 crore from Kotak Alts to advance CAR-T cancer therapies
- May 18, 2026
Indian biotech startup Cellogen Therapeutics has secured Rs 20 crore (about $2.3 million) in funding from Kotak Alternate Asset Managers to advance its most cancers and gene remedy programmes. The investment was



